Showing 1 - 10 of 6,197
This chapter takes its point of departure in the so-called Swedish paradox, according to which the Swedish NSI is plagued by low pay-off in relation to very high investments in R&D and innovation efforts. Using new data, we show that this paradox is still in operation, i.e. the productivity or...
Persistent link: https://www.econbiz.de/10005077279
A 2005 Science article by Jensen and Murray is widely cited for the proposition that 20% of human genes are patented, and has led to a pervasive assumption that thousands of human genes cannot be used, studied or even 'looked at' by researchers and healthcare providers without infringing a gene...
Persistent link: https://www.econbiz.de/10014179614
This Note applies the concept of "paradigm shifts" from the history and philosophy of science to describe how patents on biomedical research tools - inputs to basic research - can create conditions conducive to fundamental advances in scientific theory. Patents on research tools can prevent...
Persistent link: https://www.econbiz.de/10014058756
progress in biotechnology and related disciplines has increased the opportunities to treat diseases, but the firms have …
Persistent link: https://www.econbiz.de/10014501658
This paper reports on the findings of interviews conducted with Hungarian firms on their overall business and innovation strategies and innovation activities to pursue three interconnected aims: a) better understand firm behaviour by analysing qualitative features of innovation processes...
Persistent link: https://www.econbiz.de/10014145763
Operation Warp Speed (OWS) was a U.S. government-led program to accelerate the development, production, and administration of COVID-19 vaccines. The program cut the typical ten-year timeline needed to develop a new vaccine down to ten months and began vaccinating vulnerable populations within a...
Persistent link: https://www.econbiz.de/10015056157
The German biotechnology industry missed the accession of this key technology in the 1980s. Policy makers make … particular not discriminating different kinds of ?risk? in the field of biotechnology. The study combines survey data of German …
Persistent link: https://www.econbiz.de/10010297472
The German biotechnology industry missed the accession of this key technology in the 1980s. Policy makers make … particular not discriminating different kinds of ?risk? in the field of biotechnology. The study combines survey data of German …
Persistent link: https://www.econbiz.de/10005097735
A review of the types of Innovation System identified in the literature points to different models. Besides the very well-known National, Regional, Local, sectorial, and technological innovation systems, combinations of the previous can be identified, proposing sub-models such as National Open...
Persistent link: https://www.econbiz.de/10011499311
of all scientific publications of Italian biotechnology firms over the period 1990 to may 2006 and we provide evidence on …
Persistent link: https://www.econbiz.de/10009652372